Arthur S. Kirsch - Feb 20, 2025 Form 3 Insider Report for Atea Pharmaceuticals, Inc. (AVIR)

Role
Director
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Arthur S. Kirsch
Stock symbol
AVIR
Transactions as of
Feb 20, 2025
Transactions value $
$0
Form type
3
Date filed
2/24/2025, 06:47 PM
Previous filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding AVIR Common Stock 35.7K Feb 20, 2025 Direct
holding AVIR Common Stock 10K Feb 20, 2025 By trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney